Cargando…
Gliflozins: From Antidiabetic Drugs to Cornerstone in Heart Failure Therapy—A Boost to Their Utilization and Multidisciplinary Approach in the Management of Heart Failure
Heart failure (HF) is a complex, multifactorial, progressive clinical condition affecting 64.3 million people worldwide, with a strong impact in terms of morbidity, mortality and public health costs. In the last 50 years, along with a better understanding of HF physiopathology and in agreement with...
Autores principales: | Pistelli, Lorenzo, Parisi, Francesca, Correale, Michele, Cocuzza, Federica, Campanella, Francesca, de Ferrari, Tommaso, Crea, Pasquale, De Sarro, Rosalba, La Cognata, Olga, Ceratti, Simona, Recupero, Tonino, Ruocco, Gaetano, Palazzuoli, Alberto, Imbalzano, Egidio, Dattilo, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820867/ https://www.ncbi.nlm.nih.gov/pubmed/36615178 http://dx.doi.org/10.3390/jcm12010379 |
Ejemplares similares
-
Meta-analyzing the factors affecting the efficacy of gliflozins in patients with heart failure based on heart failure trials
por: Yin, Daogen, et al.
Publicado: (2021) -
Surprises in cardiology: efficacy of gliflozines in heart failure even in the absence of diabetes
por: Bragagni, Alessio, et al.
Publicado: (2021) -
Rationale and design of the Biventricular Evaluation of Gliflozins effects In chroNic Heart Failure: BEGIN‐HF study
por: Correale, Michele, et al.
Publicado: (2023) -
Short-term anti-remodeling effects of gliflozins in diabetic patients with heart failure and reduced ejection fraction: an explainable artificial intelligence approach
por: Mele, Marco, et al.
Publicado: (2023) -
In-hospital Routes of Acute Heart Failure Admissions During COVID-19
por: Ruocco, Gaetano, et al.
Publicado: (2020)